Showing results (51-60 of 61) with videos related to
Sort By:
Pageof 7
Plos One|October 6, 2017
Novel multipurpose pod-intravaginal ring for the prevention of HIV, HSV, and unintended pregnancy: Pharmacokinetic evaluation in a macaque modelJames M Smith, John A Moss, Priya Srinivasan, et al.Communications Medicine|October 14, 2022
Early SARS-CoV-2 dynamics and immune responses in unvaccinated participants of an intensely sampled longitudinal surveillance studyManjula Gunawardana, Simon Webster, Sofia Rivera, et al.Plos One|June 9, 2016
Topical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV ExposuresPriya Srinivasan, John A Moss, Manjula Gunawardana, et al.The Lancet. HIV|June 30, 2025
Safety, tolerability, and pharmacokinetics of an annual tenofovir alafenamide silicone subdermal implant in South African women: a two-part, randomised, placebo-controlled, double-blind, first-in-human, phase 1 trialTanuja N Gengiah, Lara Lewis, Ishana Harkoo, et al.Frontiers in Pharmacology|February 4, 2021
Multispecies Evaluation of a Long-Acting Tenofovir Alafenamide Subdermal Implant for HIV ProphylaxisManjula Gunawardana, Mariana Remedios-Chan, Debbie Sanchez, et al.Scientific Reports|May 17, 2022
Fundamental aspects of long-acting tenofovir alafenamide delivery from subdermal implants for HIV prophylaxisManjula Gunawardana, Mariana Remedios-Chan, Debbie Sanchez, et al.Antimicrobial Agents and Chemotherapy|September 12, 2012
Safety and pharmacokinetics of intravaginal rings delivering tenofovir in pig-tailed macaquesJohn A Moss, Amanda M Malone, Thomas J Smith, et al.Plos Medicine|September 29, 2018
Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trialKathleen L Vincent, John A Moss, Mark A Marzinke, et al.Nature Microbiology|April 6, 2023
Vaccine plus microbicide effective in preventing vaginal SIV transmission in macaquesMohammad Arif Rahman, Massimiliano Bissa, Isabela Silva de Castro, et al.AIDS Research and Human Retroviruses|April 29, 2021
Tenofovir Alafenamide for HIV Prevention: Review of the Proceedings from the Gates Foundation Long-Acting TAF Product Development MeetingJoseph W Romano, Marc M Baum, Zach R Demkovich, et al.Pageof 7